Text Size

Treatment of Acne Keloidalis Nuchae (Razor Bumps Behind the Neck) Using UV Light Therapy

This study has been completed.
Sponsor:
Collaborator:
Skin of Color Society
Information provided by:
Johns Hopkins University
ClinicalTrials.gov Identifier:
NCT01328080
First received: March 31, 2011
Last updated: September 19, 2012
Last verified: August 2012
History of Changes
  Purpose

This study is being done to evaluate the effect of targeted UV-B (a component of sunlight) on the treatment of acne keloidalis nuchae (AKN, or razor bumps on the back of the neck). The investigators believe targeted UV-B is a safe and effective way to reduce the appearance of AKN.


Condition Intervention
Acne Keloidalis Nuchae
 Radiation: Targeted UV-B

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single Blind (Investigator)
Primary Purpose: Treatment
Official Title: Improving Acne Keloidalis Nuchae by Inducing Matrix Metalloproteinases in Vivo Using Targeted Ultraviolet-B Irradiation

Resource links provided by NLM:

MedlinePlus related topics: Acne
U.S. FDA Resources

Further study details as provided by Johns Hopkins University:

Primary Outcome Measures:
  • Resolution of AKN [ Time Frame: 16 weeks ] [ Designated as safety issue: No ]

Enrollment: 8
Study Start Date: February 2011
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Targeted UV-B Radiation: Targeted UV-B
Daavlin Lumera phototherapy device (290-320 nm), dosed by patients' individual minimal erythema dose (MED)

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • age 18 or over
  • male gender
  • African-American or other black ethnicity
  • current diagnosis of acne keloidalis nuchae (razor bumps on back of neck)

Exclusion Criteria:

  • allergy to lidocaine or numbing medicine
  • history of increased sensitivity to sunlight, lupus, or porphyria
  • current use of a drug that increases sensitivity to sunlight
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01328080

Locations
United States, Maryland
Johns Hopkins Dept. of Dermatology
Baltimore, Maryland, United States, 21287
Sponsors and Collaborators
Johns Hopkins University
Skin of Color Society
  More Information

Additional Information:
Skin of Color Society (sponsor)  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Ginette Hinds, M.D., Johns Hopkins University Dept. of Dermatology
ClinicalTrials.gov Identifier: NCT01328080     History of Changes
Other Study ID Numbers: NA_00035842
Study First Received: March 31, 2011
Last Updated: September 19, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Acne Vulgaris
Acne Keloid
Acneiform Eruptions
Skin Diseases
Facial Dermatoses
Sebaceous Gland Diseases
 Keloid
Collagen Diseases
Connective Tissue Diseases
Folliculitis
Hair Diseases

ClinicalTrials.gov processed this record on May 22, 2013